1. Altogen Biosystems offers the Caki-1 Transfection Reagent among a host of 100+ cell line specific In Vitro Transfection Kits. Caki-1 Transfection Reagent is an advanced cationic lipid formulation based reagent, and it has been developed to provide high transfection efficiency with Caki-1 cells. This cell line is a good host for studying human proximal tubule epithelium. When cultured in vitro, Caki-1 cells are a monolayer and adhere to the surface of the culture flask. Other applications include drug discovery, gene expression studies, molecular and cell biology research applications. Purchase Caki-1 Transfection Kit at www.Altogen.com Leading Developer and Manufacturer of In Vivo and DNA Transfection Kits, Transfection Reagents and Electroporation Delivery Products Altogen Biosystems  848 Rainbow Blvd #823  Las Vegas  NV  89107  USA Telephone  702 349 6103  Fax  702 989-0841  email  techserv@altogen.com Products > Transfection Reagent for Caki-1 Cells, (Kidney Epithelial Cells, HTB-46)

2. The Caki-1 cell line originated from the renal carcinoma cells of a 49-year old male Caucasian patient with clear cell carcinoma. The Caki-1 cell line is tumorigenic and also displays epithelial morphology. The cell line has implications for studying human proximal tubule epithelium. The Caki-1 cell line contains few filaments, but several microvilli. Interestingly, the Caki-1 cell line has an extensive Golgi apparatus and endoplasmic reticulum as well as several small mitochondria. Caki-1 Cell Line Description and Applications Altogen Biosystems  848 Rainbow Blvd #823  Las Vegas  NV  89107  USA Telephone  702 349 6103  Fax  702 989-0841  email  techserv@altogen.com Caki-1 Cells atcc.org Products > Transfection Reagent for Caki-1 Cells, (Kidney Epithelial Cells, HTB-46) Leading Developer and Manufacturer of In Vivo and DNA Transfection Kits, Transfection Reagents and Electroporation Delivery Products

3. Caki-1 Transfection Protocol 1. Plate 10,000 - 15,000 Caki-1 cells per well in 0.5 ml of complete growth medium 12–24 hours prior to transfection 2. Wash with 1xPBS and add 0.5 ml of fresh growth medium 3. Prepare transfection complexes by mixing 40 µl of serum-free medium, 5.5 µl of transfection reagent, and 750 ng DNA (or mRNA), or 30 nM - 50 nM of siRNA (or microRNA) *Referred to a final volume including growth medium 4. Incubate transfection complexes at RT for 15 - 30 minutes 5. Optional: Add 2 µl of Complex Condenser. This reagent reduces the size of transfection complex, therefore increasing transfection efficiency; however it may increase cell toxicity 6. Add prepared transfection complexes to 0.5 ml of complete growth medium with Caki-1 cells (from step 2) 7. Incubate cells at 37ºC in a humidified CO 2 incubator 8. Assay for phenotype or target gene expression 48 - 72 hours after transfection Optional: Transfection efficiency can be increased by addition of Transfection Enhancer reagent. Add 2 µl of Transfection Enhancer reagent 12-24 hours after transfection If the viability of Caki-1 cells being transfected is affected at 16 - 24 hours post-transfection, the level of cytotoxicity can be decreased by changing the growth medium and eliminating redundant exposure of cells to transfectant Altogen Biosystems  848 Rainbow Blvd #823  Las Vegas  NV  89107  USA Telephone  702 349 6103  Fax  702 989-0841  email  techserv@altogen.com Products > Transfection Reagent for Caki-1 Cells, (Kidney Epithelial Cells, HTB-46) Leading Developer and Manufacturer of In Vivo and DNA Transfection Kits, Transfection Reagents and Electroporation Delivery Products

4. General Lipoplex-mediated Transfection Mechanism of Action Altogen Biosystems  848 Rainbow Blvd #823  Las Vegas  NV  89107  USA Telephone  702 349 6103  Fax  702 989-0841  email  techserv@altogen.com Products > Transfection Reagent for Caki-1 Cells, (Kidney Epithelial Cells, HTB-46) Leading Developer and Manufacturer of In Vivo and DNA Transfection Kits, Transfection Reagents and Electroporation Delivery Products

5. Caki-1 Transfection Kit Product Details Two component formulation enhances lipid mediated transfection efficiency Optimized easy-to-use transfection protocol provided for transfection of siRNA, DNA, mRNA, and microRNA Kit includes Transfection Enhancer reagent and recommended transfection protocol High transfection efficacy in the presence of serum Expand your RNAi application with a reagent optimized for delivery of both siRNA and plasmid Reproducible transfection results Works well for standard reverse transfection and high-throughput applications Developed and manufactured by Altogen Biosystems (www.Altogen.com) Altogen Biosystems  848 Rainbow Blvd #823  Las Vegas  NV  89107  USA Telephone  702 349 6103  Fax  702 989-0841  email  techserv@altogen.com Products > Transfection Reagent for Caki-1 Cells, (Kidney Epithelial Cells, HTB-46) Leading Developer and Manufacturer of In Vivo and DNA Transfection Kits, Transfection Reagents and Electroporation Delivery Products

6. Data Figure 1. SiRNAs targeting Lamin A/C mRNA or non-silencing control siRNA were transfected into Caki-1 cells following the recommended protocol. At 48 hours post-transfection the cells were analyzed by qRT- PCR for gene expression levels. 18S rRNA levels were used to normalize the Lamin A/C data. Values are normalized to untreated sample. Data are means ± SD (n=3). Products > Transfection Reagent for Caki-1 Cells, (Kidney Epithelial Cells, HTB-46) Leading Developer and Manufacturer of In Vivo and DNA Transfection Kits, Transfection Reagents and Electroporation Delivery Products

7. Data Products > Transfection Reagent for Caki-1 Cells, (Kidney Epithelial Cells, HTB-46) Leading Developer and Manufacturer of In Vivo and DNA Transfection Kits, Transfection Reagents and Electroporation Delivery Products Figure 2. Protein expression of Lamin A/C in Caki-1 cells. DNA plasmid expressing Lamin A/C or siRNA targeting Lamin A/C were transfected into Caki-1 cells following Altogen Biosystems transfection protocol. At 72 hours post-transfection the cells were analyzed by Western Blot for protein expression levels (normalized by total protein, 10 µg of total protein loaded per each well). Untreated cells used as a negative control.

8. Pre-optimized transfection protocol for Caki-1 cell line Compatible with DNA, small RNA (siRNA, shRNA, miRNA), mRNA, and small protein complexing Free of serum and protein of animal origin Compatible with standard and reverse transfection methods (both protocols provided in the kit manual) Easy to use Caki-1 transfection protocol ensures great performance with expedited experimental timeline Equally efficient for single or multiple transfections Can be used for transient transfection and development of stable Caki-1 cell lines Bio-degradable after endocytosis Used for preclinical research worldwide Caki-1 Transfection Kit Benefits Altogen Biosystems  848 Rainbow Blvd #823  Las Vegas  NV  89107  USA Telephone  702 349 6103  Fax  702 989-0841  email  techserv@altogen.com Products > Transfection Reagent for Caki-1 Cells, (Kidney Epithelial Cells, HTB-46) Leading Developer and Manufacturer of In Vivo and DNA Transfection Kits, Transfection Reagents and Electroporation Delivery Products